Early Predictors of Clinical Deterioration in Intermediate - High-Risk Pulmonary Embolism: Clinical Needs, Research Imperatives, and Pathways Forward.
Marco ZuinCecilia BecattiniGregory PiazzaPublished in: European heart journal. Acute cardiovascular care (2023)
A subset of intermediate-high-risk pulmonary embolism (PE) patients will suffer clinical deterioration in the early hours following the acute event. Current evidence-based guidelines for the management of acute PE have provided limited direction for identification of which intermediate-high-risk PE patients will go on to develop hemodynamic decompensation. Furthermore, a paucity of data further hampers guideline recommendations regarding the optimal approach and duration of intensive monitoring, best methods to assess the early response to anticoagulation, and the ideal window for reperfusion therapy, if decompensation threatens. The aim of the present article is to identify the current unmet needs related to the early identification of intermediate-high-risk PE patients at higher risk of clinical deterioration and mortality during the early hours after the acute cardiovascular event and suggest some potential strategies to further explore gaps in the literature.
Keyphrases
- pulmonary embolism
- end stage renal disease
- liver failure
- chronic kidney disease
- ejection fraction
- inferior vena cava
- newly diagnosed
- systematic review
- prognostic factors
- drug induced
- cardiovascular disease
- heart failure
- acute myocardial infarction
- stem cells
- risk factors
- atrial fibrillation
- coronary artery disease
- risk assessment
- venous thromboembolism
- acute coronary syndrome
- left ventricular
- acute respiratory distress syndrome
- blood brain barrier
- percutaneous coronary intervention
- subarachnoid hemorrhage
- mechanical ventilation